The HBSAg Card test is highly accurate in detecting Hepatitis B surface antigen in the blood.

Yes, patient confidentiality is strictly maintained during HBSAg testing, and results are handled discreetly by trained healthcare professionals.

No, additional tests may be required to differentiate between acute (recently acquired) and chronic (long-term) Hepatitis B infection.

The test can detect Hepatitis B surface antigen early in the course of infection, typically within a few weeks after exposure.

A positive result requires further confirmation with additional tests. Counseling and appropriate medical care will be provided to manage Hepatitis B infection effectively.

Surgeons perform a rapid assessment to identify life-threatening conditions first, then proceed with necessary surgeries to stabilize the patient.

Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.